PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.44 - 1.45
1.18 - 2.36
71.0K / 1.73M (Avg.)
-18.12 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
29.47%
Revenue growth above 1.5x 0315.HK's 2.79%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
12.43%
Positive gross profit growth while 0315.HK is negative. John Neff would see a clear operational edge over the competitor.
No Data
No Data available this quarter, please select a different quarter.
-10.38%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-275.35%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-274.29%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-274.29%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-1.21%
Share reduction while 0315.HK is at 0.65%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
13.10%
Positive OCF growth while 0315.HK is negative. John Neff would see this as a clear operational advantage vs. the competitor.
21.15%
FCF growth above 1.5x 0315.HK's 5.87%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-99.43%
Negative 10Y revenue/share CAGR while 0315.HK stands at 345.11%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-99.52%
Negative 5Y CAGR while 0315.HK stands at 286.78%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
1840.00%
3Y revenue/share CAGR above 1.5x 0315.HK's 100.85%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-224.03%
Negative 10Y OCF/share CAGR while 0315.HK stands at 185.24%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-150.91%
Negative 5Y OCF/share CAGR while 0315.HK is at 158.40%. Joel Greenblatt would question the firm’s operational model or cost structure.
-156.03%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-197.87%
Negative 10Y net income/share CAGR while 0315.HK is at 8.07%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-124.60%
Negative 5Y net income/share CAGR while 0315.HK is 1034.76%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-106.58%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
160.62%
3Y equity/share CAGR above 1.5x 0315.HK's 10.62%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-99.99%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-99.99%
Negative 5Y dividend/share CAGR while 0315.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-100.00%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-36.26%
We have a declining book value while 0315.HK shows 3.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.